Shandong Lanjin Pharmaceuticals Co.,Ltd   Report issue

For profit Phase 3
Founded: Jinan China (2001)
Status: No NME R&D (2001)

Organization Overview

First Clinical Trial
2010
NCT01570049
First Marketed Drug
2019
rosuvastatin (crestor)
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

SHANDONG